WAVE Life Sciences Ltd.

WVE Healthcare Biotechnology

In the quarter to June 2026, revenue fell 73.9%, EPS fell 9.68% and free cash flow fell 17.6%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

3.12 0.07 −2.19%
Market cap
$628.6M
P/E
0.0×
Fwd P/E
−6.2×
Dividend yield
—
F-score
3/9
Altman Z
11.34
Beneish M
−2.44
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Total current assets
507.51 561.27 614.81 215.49
Total non-current assets
50.81 22.27 23.69 25.89
Total Assets
558.32 583.54 638.50 241.38
Total current liabilities
50.82 49.83 95.07 85.90
Total non-current liabilities
53.99 21.98 25.08 30.93
Total liabilities
104.80 71.81 120.14 116.83
Common Equity (Total)
453.52 511.73 518.36 124.55
Shareholders Equity (Total)
453.52 511.73 518.36 124.55

Show all line items

In millions of $ except per-share values · columns are period end dates